½ÃÀ庸°í¼­
»óǰÄÚµå
1654363

ÀÇ·á¿ë 3D ÇÁ¸°ÆÃ ÇÃ¶ó½ºÆ½ ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : À¯Çüº°, Çü»óº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2025-2030³â)

Medical 3D Printing Plastics Market Size, Share & Trends Analysis Report By Type (ABS, PEEK, Photopolymer, Polyamide), By Form (Filament, Powder, Ink), By Region, And Segment Forecasts, 2025 - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 100 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ÀÇ·á¿ë 3D ÇÁ¸°ÆÃ ÇÃ¶ó½ºÆ½ ½ÃÀåÀÇ ¼ºÀå°ú µ¿Çâ :

Grand View Research, Inc.ÀÇ »õ·Î¿î º¸°í¼­¿¡ µû¸£¸é ¼¼°èÀÇ ÀÇ·á¿ë 3D ÇÁ¸°ÆÃ ÇÃ¶ó½ºÆ½ ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 26¾ï 3,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2025-2030³â ¿¬Æò±Õ 25.1%ÀÇ ¼ºÀå·üÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÇ·á¿ë 3D ÇÁ¸°ÆÃ ÇÃ¶ó½ºÆ½¿¡ ´ëÇÑ ¼ö¿ä´Â COVID-19 ÆÒµ¥¹Í »óȲÀ¸·Î ÀÎÇØ ´«¿¡ ¶ç´Â ¼Óµµ·Î Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Àü¿°º´À¸·Î ÀÎÇØ ¸¶½ºÅ©¿Í Ä¿¹ö, Àå°©, ¸Ó¸®¿Í ½Å¹ß Ä¿¹ö, ±âŸ ÀÇ·á Àåºñ¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇß½À´Ï´Ù.

¾çÀûÀ¸·Î, Æ÷ÅäÆú¸®¸Ó À¯Çü ºÎ¹®Àº 2019³â °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¿¹Ãø ±â°£ Áß ¼±µÎ¸¦ À¯ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Æ÷ÅäÆú¸®¸Ó´Â º¸Ã»±â, Ä¡°ú¿ë ÀÓÇöõÆ®, ÆäÀ̽º ¸¶½ºÅ© µî ´Ù¾çÇÑ ÀÇ·á¿ë ºÎǰ Á¦Á¶¿¡ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. Æ÷ÅäÆú¸®¸Ó·Î Á¦Á¶µÈ ºÎǰÀº ³ôÀº Á¤¹Ðµµ¿Í ¸Å²ô·¯¿î Ç¥¸é ¸¶°¨À» °¡Áö°í ÀÖÀ¸¸ç, º¹ÀâÇÑ Çü»óµµ ½±°Ô Á¦Á¶ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ¯¼ºÀ¸·Î ÀÎÇØ ÀÇ·á¿ë 3D ÇÁ¸°ÆÃ °øÁ¤¿¡ ÀûÇÕÇÕ´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾çÀº Make in India¿Í °°Àº Á¤ºÎ ±¸»óÀÇ Á¸Àç, ÀÇ·á Á¦Ç° Á¦Á¶¾÷ü Áõ°¡, °ø°ø ±â°ü»Ó¸¸ ¾Æ´Ï¶ó ¹Î°£ ±â¾÷ÀÇ ÀÇ·á¿ë 3D ÇÁ¸°ÆÃ ÇÃ¶ó½ºÆ½ ºÐ¾ß¿¡ ´ëÇÑ R&D ÅõÀÚ Áõ°¡ µî ´Ù¾çÇÑ ¿äÀÎÀ¸·Î ÀÎÇØ ÇâÈÄ ¼ö³â°£ »ó´çÇÑ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù. ¶ÇÇÑ COVID-19 ÆÒµ¥¹Í ÀÌÈÄ ´Ù¾çÇÑ ÀÇ·á Á¦Ç° Á¦Á¶ ±â¾÷ÀÌ Àεµ¿¡ Á¦Á¶ ½Ã¼³À» ¼³¸³ÇÏ´Â °ÍÀ» °í·ÁÇϱ⠽ÃÀÛÇß½À´Ï´Ù.

ÀÇ·á¿ë 3D ÇÁ¸°ÆÃ ÇÃ¶ó½ºÆ½ ½ÃÀå : ºÐ¼® °³¿ä

  • ÀÇ·á¿ë 3D ÇÁ¸°ÆÃ ÇÃ¶ó½ºÆ½ »ý»ê¿¡ »ç¿ëµÇ´Â ÁÖ¿ä ¿ø·á´Â ½ºÆ¼·», ¾Æ¹Ìµå, Á¥»ê, ¿¡Å׸£, ±Û¸®ÄÝ, ¿¡Æ¿·» µî ¼®À¯ ¹× õ¿¬°¡½ºÀÇ ºÎ»ê¹°ÀÎ ½ºÆ¼·», ¾Æ¹Ìµå, ¿¡Æ¿·» µîÀÌ ÀÖ½À´Ï´Ù.
  • ¾çÀû Ãø¸é¿¡¼­´Â Æ÷ÅäÆú¸®¸Ó À¯ÇüÀÌ 2024³â ½ÃÀå¿¡¼­ µÎµå·¯Áø Á¡À¯À²À» Â÷ÁöÇϰí ÀÖÀ¸¸ç, ¿¹Ãø ±â°£ Áß Å« ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
  • Çʶó¸àÆ®Çü ºÎ¹®Àº ¼¼°è ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖÀ¸¸ç, 2024³â Àüü ¸ÅÃâÀÇ 75.5%¸¦ Â÷ÁöÇß½À´Ï´Ù.
  • 2024³â ÇöÀç ºÏ¹Ì°¡ Àüü ¸ÅÃâÀÇ 45.3%¸¦ Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. Æ÷Àå Á¦Ç° Á¦Á¶¾÷üÀÇ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ÀÌ Áö¿ª ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ºÐ¼® ¹æ¹ý¡¤¹üÀ§

Á¦2Àå °³¿ä

Á¦3Àå ÀÇ·á¿ë 3D ÇÁ¸°ÆÃ ÇÃ¶ó½ºÆ½ ½ÃÀå : º¯µ¿ ¿äÀΡ¤°æÇ⡤¹üÀ§

  • ¼¼°èÀÇ ÀÇ·á¿ë 3D ÇÁ¸°ÆÃ ÇÃ¶ó½ºÆ½ ½ÃÀå Àü¸Á
  • ¾÷°èÀÇ ¹ë·ùüÀÎ ºÐ¼®
  • ¿ëµµÀÇ °³¿ä
  • Æò±Õ °¡°Ý µ¿Ç⠺м®
  • ¼ö±Þ °¸ ºÐ¼®(2024³â)
  • ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©
    • Á¤Ã¥°ú Àå·ÁÃ¥ Ç÷£
    • Ç¥Áذú ÄÄÇöóÀ̾ð½º
    • ±ÔÁ¦ ¿µÇ⠺м®
  • ½ÃÀå ¿ªÇÐ
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
    • ¾÷°èÀÇ °úÁ¦
  • Porter's Five Forces ºÐ¼®
    • °ø±Þ¾÷üÀÇ Èû
    • ±¸¸ÅÀÚÀÇ Èû
    • ´ëüÀÇ À§Çù
    • ½Å±Ô Âü¿©·ÎºÎÅÍÀÇ À§Çù
    • °æÀï ±â¾÷ °£ °æÀï °ü°è
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû ¿äÀÎ
    • °æÁ¦Àû ¿äÀÎ
    • »çȸÀû ¿äÀÎ
    • ±â¼úÀû ¿äÀÎ
    • ȯ°æÀû ¿äÀÎ
    • ¹ýÀû ¿äÀÎ

Á¦4Àå ÀÇ·á¿ë 3D ÇÁ¸°ÆÃ ÇÃ¶ó½ºÆ½ ½ÃÀå : À¯Çüº° Àü¸Á¡¤ÃßÁ¤¡¤¿¹Ãø

  • ÀÇ·á¿ë 3D ÇÁ¸°ÆÃ ÇÃ¶ó½ºÆ½ ½ÃÀå : º¯µ¿ ºÐ¼®, À¯Çüº°(2024³â¡¤2030³â)
    • ¾Û¼³·çÆ®
    • PEEK
    • PETG
    • Æ÷ÅäÆú¸®¸Ó
    • Æú¸®¾Æ¹Ìµå
    • Æú¸®À¯»ê

Á¦5Àå ÀÇ·á¿ë 3D ÇÁ¸°ÆÃ ÇÃ¶ó½ºÆ½ ½ÃÀå : Çü»óº° Àü¸Á¡¤ÃßÁ¤¡¤¿¹Ãø

  • ÀÇ·á¿ë 3D ÇÁ¸°ÆÃ ÇÃ¶ó½ºÆ½ ½ÃÀå : º¯µ¿ ºÐ¼®, Çü»óº°(2024³â¡¤2030³â)
    • Çʶó¸àÆ®
    • ºÐ¸»
    • À×Å©

Á¦6Àå ÀÇ·á¿ë 3D ÇÁ¸°ÆÃ ÇÃ¶ó½ºÆ½ ½ÃÀå : Áö¿ªº° Àü¸Á¡¤ÃßÁ¤¡¤¿¹Ãø

  • Áö¿ªº° ½º³À¼ô
  • ÀÇ·á¿ë 3D ÇÁ¸°ÆÃ ÇÃ¶ó½ºÆ½ ½ÃÀå : º¯µ¿ ºÐ¼®, Áö¿ªº°(2024³â¡¤2030³â)
  • ºÏ¹Ì
    • ½ÃÀå Ã߻ꡤ¿¹Ãø(2018-2030³â)
    • À¯Çüº°(2018-2030³â)
    • Çü»óº°(2018-2030³â)
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • ½ÃÀå Ã߻ꡤ¿¹Ãø(2018-2030³â)
    • À¯Çüº°(2018-2030³â)
    • Çü»óº°(2018-2030³â)
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ½ÃÀå Ã߻ꡤ¿¹Ãø(2018-2030³â)
    • À¯Çüº°(2018-2030³â)
    • Çü»óº°(2018-2030³â)
    • Áß±¹
    • Àεµ
    • ÀϺ»
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ½ÃÀå Ã߻ꡤ¿¹Ãø(2018-2030³â)
    • À¯Çüº°(2018-2030³â)
    • Çü»óº°(2018-2030³â)
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ½ÃÀå Ã߻ꡤ¿¹Ãø(2018-2030³â)
    • À¯Çüº°(2018-2030³â)
    • Çü»óº°(2018-2030³â)
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹

Á¦7Àå °æÀï ±¸µµ

  • Ãֽе¿Çâ°ú ¿µÇ⠺м® : ÁÖ¿ä ½ÃÀå Âü¿© ±â¾÷º°
  • º¥´õ ±¸µµ
    • ±â¾÷ ºÐ·ù
    • ÁÖ¿ä À¯Åë¾÷ü¡¤Ã¤³Î ÆÄÆ®³Ê ¸®½ºÆ®
    • ÀáÀçÀû °í°´/ÃÖÁ¾»ç¿ëÀÚ ¸®½ºÆ®
  • °æÀï ¿ªÇÐ
    • °æÀï º¥Ä¡¸¶Å·
    • Àü·« ÁöµµÁ¦ÀÛ
    • È÷Æ®¸Ê ºÐ¼®
  • ±â¾÷ °³¿ä/»óÀå±â¾÷
    • 3D Systems, Inc.
    • Apium Additive Technologies GmbH
    • Arkema
    • DSM
    • ENVISIONTEC, INC.
    • Evonik Industries AG
    • Proclaim Health
    • SABIC
    • Solvay
    • Stratasys Ltd.
    • Victrex plc.
KSA 25.03.19

Medical 3D Printing Plastics Market Growth & Trends:

The global medical 3D printing plastics market size is expected to reach USD 2.63 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 25.1% from 2025 to 2030. Demand for medical 3D printing plastics is ascending at a prominent rate owing to the COVID-19 pandemic situation. The pandemic situation caused a sudden increase in demand for face mask and covers, gloves, head and shoes cover, and other medical devices.

In terms of volume, the photopolymer type segment accounted for the largest share in the year 2019 and is anticipated to maintain its lead over the forecast years. Photopolymers are used to produce various medical components, including hearing aid, dental implants, and face mask. Components produced using photopolymer have high accuracy as well as smooth surface finish and complex shapes can be produced easily. These properties make it suitable for medical 3D printing process.

Asia Pacific is anticipated to witness substantial growth over the coming years owing to various factors such as presence of government initiatives, such as Make in India, rising number of medical products manufacturers, and increasing R&D investments in the medical 3D printing plastics sector by private as well as public organizations. In addition, various medical product manufacturing companies have started looking towards India for establishing manufacturing facilities post COVID-19 pandemic situation.

Medical 3D Printing Plastics Market Report Highlights:

  • Key raw materials utilized in the production of medical 3D printing plastics include styrene, amides, lactic acid, ether, glycols, and ethylene, which are by products of crude oil and natural gas
  • In terms of volume, the photopolymer type segment accounted for a prominent share in the market in 2024 and is expected to witness significant growth over the forecast period
  • The filament form segment dominated the global market and accounted for 75.5% share of the overall revenue in 2024
  • As of 2024, North America accounted for 45.3% share of the overall revenue. Increasing focus of packaging product manufacturers is assisting the market growth in region.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources & Third-Party Perspectives
    • 1.3.4. Primary Research
  • 1.4. Information Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Data Visualization
  • 1.6. Data Validation & Publishing

Chapter 2. Executive Summary

  • 2.1. Market Insights
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. Medical 3D Printing Plastics Market Variables, Trends & Scope

  • 3.1. Global Medical 3D Printing Plastics Market Outlook
  • 3.2. Industry Value Chain Analysis
  • 3.3. Average Price Trend Analysis
  • 3.4. Supply-Demand Gap Analysis, 2024
  • 3.5. Regulatory Framework
    • 3.5.1. Policies and Incentive Plans
    • 3.5.2. Standards and Compliances
    • 3.5.3. Regulatory Impact Analysis
  • 3.6. Market Dynamics
    • 3.6.1. Market Driver Analysis
    • 3.6.2. Market Restraint Analysis
    • 3.6.3. Industry Challenges
  • 3.7. Porter's Five Forces Analysis
    • 3.7.1. Supplier Power
    • 3.7.2. Buyer Power
    • 3.7.3. Substitution Threat
    • 3.7.4. Threat from New Entrant
    • 3.7.5. Competitive Rivalry
  • 3.8. PESTEL Analysis
    • 3.8.1. Political Landscape
    • 3.8.2. Economic Landscape
    • 3.8.3. Social Landscape
    • 3.8.4. Technological Landscape
    • 3.8.5. Environmental Landscape
    • 3.8.6. Legal Landscape

Chapter 4. Medical 3D Printing Plastics Market: Type Outlook Estimates & Forecasts

  • 4.1. Medical 3D Printing Plastics Market: Type Movement Analysis, 2024 & 2030
    • 4.1.1. ABS
      • 4.1.1.1. Market Estimates and Forecast, 2018 - 2030 (Tons) (USD Million)
    • 4.1.2. PEEK
      • 4.1.2.1. Market Estimates and Forecast, 2018 - 2030 (Tons) (USD Million)
    • 4.1.3. PETG
      • 4.1.3.1. Market Estimates and Forecast, 2018 - 2030 (Tons) (USD Million)
    • 4.1.4. Photopolymer
      • 4.1.4.1. Market Estimates and Forecast, 2018 - 2030 (Tons) (USD Million)
    • 4.1.5. Polyamide
      • 4.1.5.1. Market Estimates and Forecast, 2018 - 2030 (Tons) (USD Million)
    • 4.1.6. Polylactic Acid
      • 4.1.6.1. Market Estimates and Forecast, 2018 - 2030 (Tons) (USD Million)

Chapter 5. Medical 3D Printing Plastics Market: Form Outlook Estimates & Forecasts

  • 5.1. Medical 3D Printing Plastics Market: Form Movement Analysis, 2024 & 2030
    • 5.1.1. Filament
      • 5.1.1.1. Market Estimates and Forecast, 2018 - 2030 (Tons) (USD Million)
    • 5.1.2. Powder
      • 5.1.2.1. Market Estimates and Forecast, 2018 - 2030 (Tons) (USD Million)
    • 5.1.3. Ink
      • 5.1.3.1. Market Estimates and Forecast, 2018 - 2030 (Tons) (USD Million)

Chapter 6. Medical 3D Printing Plastics Market Regional Outlook Estimates & Forecasts

  • 6.1. Regional Snapshot
  • 6.2. Medical 3D Printing Plastics Market: Regional Movement Analysis, 2024 & 2030
  • 6.3. North America
    • 6.3.1. Market Estimates and Forecast, 2018 - 2030 (Tons) (USD Million)
    • 6.3.2. Market Estimates and Forecast, By Type, 2018 - 2030 (Tons) (USD Million)
    • 6.3.3. Market Estimates and Forecast, By Form, 2018 - 2030 (Tons) (USD Million)
    • 6.3.4. U.S.
      • 6.3.4.1. Market Estimates and Forecast, 2018 - 2030 (Tons) (USD Million)
      • 6.3.4.2. Market Estimates and Forecast, By Type, 2018 - 2030 (Tons) (USD Million)
      • 6.3.4.3. Market Estimates and Forecast, By Form, 2018 - 2030 (Tons) (USD Million)
    • 6.3.5. Canada
      • 6.3.5.1. Market Estimates and Forecast, 2018 - 2030 (Tons) (USD Million)
      • 6.3.5.2. Market Estimates and Forecast, By Type, 2018 - 2030 (Tons) (USD Million)
      • 6.3.5.3. Market Estimates and Forecast, By Form, 2018 - 2030 (Tons) (USD Million)
    • 6.3.6. Mexico
      • 6.3.6.1. Market Estimates and Forecast, 2018 - 2030 (Tons) (USD Million)
      • 6.3.6.2. Market Estimates and Forecast, By Type, 2018 - 2030 (Tons) (USD Million)
      • 6.3.6.3. Market Estimates and Forecast, By Form, 2018 - 2030 (Tons) (USD Million)
  • 6.4. Europe
    • 6.4.1. Market Estimates and Forecast, 2018 - 2030 (Tons) (USD Million)
    • 6.4.2. Market Estimates and Forecast, By Type, 2018 - 2030 (Tons) (USD Million)
    • 6.4.3. Market Estimates and Forecast, By Form, 2018 - 2030 (Tons) (USD Million)
    • 6.4.4. Germany
      • 6.4.4.1. Market Estimates and Forecast, 2018 - 2030 (Tons) (USD Million)
      • 6.4.4.2. Market Estimates and Forecast, By Type, 2018 - 2030 (Tons) (USD Million)
      • 6.4.4.3. Market Estimates and Forecast, By Form, 2018 - 2030 (Tons) (USD Million)
    • 6.4.5. UK
      • 6.4.5.1. Market Estimates and Forecast, 2018 - 2030 (Tons) (USD Million)
      • 6.4.5.2. Market Estimates and Forecast, By Type, 2018 - 2030 (Tons) (USD Million)
      • 6.4.5.3. Market Estimates and Forecast, By Form, 2018 - 2030 (Tons) (USD Million)
    • 6.4.6. France
      • 6.4.6.1. Market Estimates and Forecast, 2018 - 2030 (Tons) (USD Million)
      • 6.4.6.2. Market Estimates and Forecast, By Type, 2018 - 2030 (Tons) (USD Million)
      • 6.4.6.3. Market Estimates and Forecast, By Form, 2018 - 2030 (Tons) (USD Million)
    • 6.4.7. Italy
      • 6.4.7.1. Market Estimates and Forecast, 2018 - 2030 (Tons) (USD Million)
      • 6.4.7.2. Market Estimates and Forecast, By Type, 2018 - 2030 (Tons) (USD Million)
      • 6.4.7.3. Market Estimates and Forecast, By Form, 2018 - 2030 (Tons) (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Market Estimates and Forecast, 2018 - 2030 (Tons) (USD Million)
    • 6.5.2. Market Estimates and Forecast, By Type, 2018 - 2030 (Tons) (USD Million)
    • 6.5.3. Market Estimates and Forecast, By Form, 2018 - 2030 (Tons) (USD Million)
    • 6.5.4. China
      • 6.5.4.1. Market Estimates and Forecast, 2018 - 2030 (Tons) (USD Million)
      • 6.5.4.2. Market Estimates and Forecast, By Type, 2018 - 2030 (Tons) (USD Million)
      • 6.5.4.3. Market Estimates and Forecast, By Form, 2018 - 2030 (Tons) (USD Million)
    • 6.5.5. India
      • 6.5.5.1. Market Estimates and Forecast, 2018 - 2030 (Tons) (USD Million)
      • 6.5.5.2. Market Estimates and Forecast, By Type, 2018 - 2030 (Tons) (USD Million)
      • 6.5.5.3. Market Estimates and Forecast, By Form, 2018 - 2030 (Tons) (USD Million)
    • 6.5.6. Japan
      • 6.5.6.1. Market Estimates and Forecast, 2018 - 2030 (Tons) (USD Million)
      • 6.5.6.2. Market Estimates and Forecast, By Type, 2018 - 2030 (Tons) (USD Million)
      • 6.5.6.3. Market Estimates and Forecast, By Form, 2018 - 2030 (Tons) (USD Million)
  • 6.6. Latin America
    • 6.6.1. Market Estimates and Forecast, 2018 - 2030 (Tons) (USD Million)
    • 6.6.2. Market Estimates and Forecast, By Type, 2018 - 2030 (Tons) (USD Million)
    • 6.6.3. Market Estimates and Forecast, By Form, 2018 - 2030 (Tons) (USD Million)
    • 6.6.4. Brazil
      • 6.6.4.1. Market Estimates and Forecast, 2018 - 2030 (Tons) (USD Million)
      • 6.6.4.2. Market Estimates and Forecast, By Type, 2018 - 2030 (Tons) (USD Million)
      • 6.6.4.3. Market Estimates and Forecast, By Form, 2018 - 2030 (Tons) (USD Million)
    • 6.6.5. Argentina
      • 6.6.5.1. Market Estimates and Forecast, 2018 - 2030 (Tons) (USD Million)
      • 6.6.5.2. Market Estimates and Forecast, By Type, 2018 - 2030 (Tons) (USD Million)
      • 6.6.5.3. Market Estimates and Forecast, By Form, 2018 - 2030 (Tons) (USD Million)
  • 6.7. Middle East & Africa
    • 6.7.1. Market Estimates and Forecast, 2018 - 2030 (Tons) (USD Million)
    • 6.7.2. Market Estimates and Forecast, By Type, 2018 - 2030 (Tons) (USD Million)
    • 6.7.3. Market Estimates and Forecast, By Form, 2018 - 2030 (Tons) (USD Million)
    • 6.7.4. Saudi Arabia
      • 6.7.4.1. Market Estimates and Forecast, 2018 - 2030 (Tons) (USD Million)
      • 6.7.4.2. Market Estimates and Forecast, By Type, 2018 - 2030 (Tons) (USD Million)
      • 6.7.4.3. Market Estimates and Forecast, By Form, 2018 - 2030 (Tons) (USD Million)
    • 6.7.5. South Africa
      • 6.7.5.1. Market Estimates and Forecast, 2018 - 2030 (Tons) (USD Million)
      • 6.7.5.2. Market Estimates and Forecast, By Type, 2018 - 2030 (Tons) (USD Million)
      • 6.7.5.3. Market Estimates and Forecast, By Form, 2018 - 2030 (Tons) (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Vendor Landscape
    • 7.2.1. Company Categorization
    • 7.2.2. List of Key Distributors and Channel Partners
    • 7.2.3. List of Potential Customers/End Users
  • 7.3. Competitive Dynamics
    • 7.3.1. Competitive Benchmarking
    • 7.3.2. Strategy Mapping
    • 7.3.3. Heat Map Analysis
  • 7.4. Company Profiles/Listing
    • 7.4.1. 3D Systems, Inc.
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Strategic Initiatives
    • 7.4.2. Apium Additive Technologies GmbH
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Strategic Initiatives
    • 7.4.3. Arkema
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Strategic Initiatives
    • 7.4.4. DSM
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Strategic Initiatives
    • 7.4.5. ENVISIONTEC, INC.
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Strategic Initiatives
    • 7.4.6. Evonik Industries AG
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Strategic Initiatives
    • 7.4.7. Proclaim Health
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Strategic Initiatives
    • 7.4.8. SABIC
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Strategic Initiatives
    • 7.4.9. Solvay
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Strategic Initiatives
    • 7.4.10. Stratasys Ltd.
      • 7.4.10.1. Participant's Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Strategic Initiatives
    • 7.4.11. Victrex plc.
      • 7.4.11.1. Participant's Overview
      • 7.4.11.2. Financial Performance
      • 7.4.11.3. Product Benchmarking
      • 7.4.11.4. Strategic Initiatives
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦